Summary：**OpenAI stuns Trump administration with 5% stake offer amid US AI scrutiny***Introduction* In a su

**OpenAI stuns Trump administration with 5% stake offer amid US AI scrutiny**

*Introduction*
In a surprising move that has reverberated through Washington and Silicon Valley, OpenAI announced on Monday that it is prepared to sell a 5 % equity stake to a consortium linked to the Trump administration. The offer comes as the United States intensifies its review of artificial‑intelligence technologies, with lawmakers expressing concerns over national security, data privacy, and the competitive edge of foreign AI firms. Analysts say the proposal could reshape the relationship between the federal government and one of the world’s leading AI labs.

*Key Developments*
OpenAI’s statement, released via its corporate blog, described the stake as a “strategic partnership” intended to align the company’s research agenda with U.S. policy objectives. The consortium, reportedly composed of former administration officials and private investors, would gain board observation rights and access to certain non‑proprietary model outputs. The deal is contingent on a thorough review by the Committee on Foreign Investment in the United States (CFIUS) and the newly formed AI Safety Board, both of which have heightened their oversight of advanced machine‑learning projects since early 2024.

Industry insiders note that the 5 % figure is modest compared with the valuations OpenAI has attracted from venture capital firms—most recently a $10 billion round that placed the company’s worth above $80 billion. Nevertheless, the political symbolism is significant: it marks the first time a major AI developer has offered direct equity to a group tied to a former presidential administration.

*Industry Analysis*
The move reflects a broader trend of tech firms seeking to pre‑empt regulatory friction by embedding government stakeholders early in their capital structures. Similar tactics have been employed by semiconductor manufacturers facing export controls and by social‑media platforms navigating content‑moderation pressures. For OpenAI, the stake could provide a buffer against potential restrictions on model exports or limitations on the use of its GPT‑series in defense applications.

However, critics warn that such entanglements risk compromising the lab’s independence. “When a government entity holds equity, even a minority share, the perception of influence can affect research priorities and public trust,” said Dr. Lena Morales,